Literature DB >> 1899118

Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure.

J A Bauer1, H L Fung.   

Abstract

S-nitrosothiols are potent in vitro vasodilators, but little is known about their in vivo action. In this study, we compared the effects of S-nitroso N-acetyl penicillamine (SNAP) and nitroglycerin (NTG) on left ventricular (LV) hemodynamics in congestive heart failure rats. By using a twoday crossover design, stepwise i.v. infusions of SNAP or NTG at 3, 5 and 8 micrograms/min were administered for 30 min each, followed by a dose of 10 micrograms/min over the next 10 h. LV end-diastolic and peak-systolic pressures (LVEDP and LVPSP, respectively) were measured at selected intervals. SNAP and NTG produced maximal LVEDP reductions of 46 and 44%, respectively, at the highest infusion rate. However, at the lower doses, greater reductions of LVEDP were seen with SNAP. NTG had a smaller effect on LVPSP (maximum 6% reduction) than SNAP (maximum reduction of 15%). During the 10-h infusion of NTG, LVEDP gradually returned to base-line values, indicating the development of tolerance, despite relatively constant plasma levels of NTG over the infusion period. Tolerance in LVEDP effects was not observed during the 10-h infusion of SNAP. In the presence of NTG tolerance, rats were still responsive to SNAP (mean reduction of LVEDP 24%), suggesting the absence of cross-tolerance between these two nitrovasodilators. These results suggest that SNAP is a more potent in vivo vasodilator than NTG, has more arterial action than NTG and is less prone to produce LV hemodynamic tolerance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899118

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

1.  Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy.

Authors:  I L Megson; N Sogo; F A Mazzei; A R Butler; J C Walton; D J Webb
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Application of pharmacodynamic modeling for designing time-variant dosing regimens to overcome nitroglycerin tolerance in experimental heart failure.

Authors:  J A Bauer; J P Balthasar; H L Fung
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

3.  N-Substituted analogues of S-nitroso-N-acetyl-D,L-penicillamine: chemical stability and prolonged nitric oxide mediated vasodilatation in isolated rat femoral arteries.

Authors:  I L Megson; S Morton; I R Greig; F A Mazzei; R A Field; A R Butler; G Caron; A Gasco; R Fruttero; D J Webb
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

4.  Effects of obesity on the pharmacodynamics of nitroglycerin in conscious rats.

Authors:  Ellen Q Wang; Ho-Leung Fung
Journal:  AAPS PharmSci       Date:  2002

5.  Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance.

Authors:  Nazish Sayed; David D Kim; Xavier Fioramonti; Toru Iwahashi; Walter N Durán; Annie Beuve
Journal:  Circ Res       Date:  2008-07-31       Impact factor: 17.367

6.  S-nitroso human serum albumin given after LPS challenge reduces acute lung injury and prolongs survival in a rat model of endotoxemia.

Authors:  A Jakubowski; N Maksimovich; R Olszanecki; A Gebska; H Gasser; B K Podesser; S Hallström; S Chlopicki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

7.  Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humans.

Authors:  Cynthia Sung; Tom J Parry; Todd A Riccobene; Angela Mahoney; Viktor Roschke; James Murray; Mi Li Gu; Jeffrey K Glenn; Florence Caputo; Cindy Farman; Daniel J Odenheimer
Journal:  AAPS PharmSci       Date:  2002

8.  Effect of apparent elimination half-life on nitroglycerin-induced hemodynamic rebound in experimental heart failure.

Authors:  J A Bauer; H L Fung
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

9.  Chemical stabilization of a vasoactive S-nitrosothiol with cyclodextrins without loss of pharmacologic activity.

Authors:  J A Bauer; H L Fung
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

10.  Release of nitric oxide from glyceryl trinitrate by captopril but not enalaprilat: in vitro and in vivo studies.

Authors:  D Salvemini; A Pistelli; V Mollace
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.